Research statistics

Kisspeptin-54 (Metastin) research: publications and trials

What has been published on Kisspeptin-54 (Metastin): PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Kisspeptin-54 (Metastin) works or is safe. For what it is and what the studies found, see the Kisspeptin-54 (Metastin) profile.
Automated weekly refresh · data through November 8, 2026

At a glance

Publications, all years

189

Since 2001

Publications in 2026 so far

7

Through November 8, 2026

Human clinical research

31.7%

60 of 189 classified

Registered clinical trials

15

ClinicalTrials.gov

Randomized controlled trials

11

Publications reporting an RCT in people

Systematic reviews and meta-analyses

2

Preclinical studies

49.2%

70 animal · 23 in vitro · 0 computational

Records that only mention it

42

Not counted above

Status in the library: Research only.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.
  • The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.

Publications by year

Kisspeptin-54 (Metastin) publications by year and evidence

2001, Preclinical (animal, in vitro, computational): 2 of 22002, Preclinical (animal, in vitro, computational): 1 of 12003, Human clinical research: 1 of 42003, Preclinical (animal, in vitro, computational): 2 of 42003, Reviews and meta-analyses: 1 of 42004, Preclinical (animal, in vitro, computational): 8 of 92004, Reviews and meta-analyses: 1 of 92005, Human clinical research: 3 of 122005, Preclinical (animal, in vitro, computational): 7 of 122005, Reviews and meta-analyses: 2 of 122006, Human clinical research: 1 of 102006, Preclinical (animal, in vitro, computational): 5 of 102006, Reviews and meta-analyses: 3 of 102006, Other and not yet classified: 1 of 102007, Human clinical research: 5 of 122007, Preclinical (animal, in vitro, computational): 6 of 122007, Reviews and meta-analyses: 1 of 122008, Human clinical research: 2 of 132008, Preclinical (animal, in vitro, computational): 4 of 132008, Reviews and meta-analyses: 4 of 132008, Other and not yet classified: 3 of 132009, Human clinical research: 5 of 122009, Preclinical (animal, in vitro, computational): 4 of 122009, Reviews and meta-analyses: 3 of 122010, Human clinical research: 5 of 92010, Preclinical (animal, in vitro, computational): 1 of 92010, Reviews and meta-analyses: 3 of 92011, Preclinical (animal, in vitro, computational): 1 of 12012, Human clinical research: 4 of 102012, Preclinical (animal, in vitro, computational): 6 of 102013, Human clinical research: 5 of 82013, Preclinical (animal, in vitro, computational): 3 of 82014, Human clinical research: 7 of 132014, Preclinical (animal, in vitro, computational): 4 of 132014, Reviews and meta-analyses: 1 of 132014, Other and not yet classified: 1 of 132015, Human clinical research: 4 of 72015, Preclinical (animal, in vitro, computational): 3 of 72016, Human clinical research: 2 of 52016, Preclinical (animal, in vitro, computational): 2 of 52016, Reviews and meta-analyses: 1 of 52017, Human clinical research: 1 of 42017, Preclinical (animal, in vitro, computational): 2 of 42017, Reviews and meta-analyses: 1 of 42018, Human clinical research: 3 of 92018, Preclinical (animal, in vitro, computational): 5 of 92018, Reviews and meta-analyses: 1 of 92019, Human clinical research: 1 of 52019, Preclinical (animal, in vitro, computational): 2 of 52019, Reviews and meta-analyses: 2 of 52020, Human clinical research: 2 of 52020, Preclinical (animal, in vitro, computational): 2 of 52020, Reviews and meta-analyses: 1 of 52021, Preclinical (animal, in vitro, computational): 5 of 62021, Other and not yet classified: 1 of 62022, Human clinical research: 2 of 62022, Preclinical (animal, in vitro, computational): 3 of 62022, Reviews and meta-analyses: 1 of 62023, Human clinical research: 1 of 52023, Preclinical (animal, in vitro, computational): 4 of 52024, Preclinical (animal, in vitro, computational): 4 of 62024, Reviews and meta-analyses: 2 of 62025, Human clinical research: 4 of 82025, Preclinical (animal, in vitro, computational): 2 of 82025, Reviews and meta-analyses: 2 of 82026 (to date), Human clinical research: 2 of 72026 (to date), Preclinical (animal, in vitro, computational): 5 of 7Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified05101520012007201320192026*
Counted PubMed publications by year of first publication. * 2026 runs to November 8, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
200102002
200201001
200312104
200408109
2005372012
2006153110
2007561012
2008244313
2009543012
201051309
201101001
2012460010
201353008
2014741113
201543007
201622105
201712104
201835109
201912205
202022105
202105016
202223106
202314005
202404206
202542208
2026 (to date)25007

Study types

Animal study70
Observational human study33
Review28
In vitro study23
Other clinical trial15
Randomized controlled trial11
Editorial, letter or other6
Case report1
Meta-analysis1
Systematic review1

Research areas

From MeSH major topics. A paper can be in several areas.

Reproductive and sexual health111
Endocrinology85
Oncology56
Neurological and mental health38
Metabolic health8
Gastrointestinal6
Immune system6
Cardiovascular5
Obesity and weight management5
Dermatology4
Longevity and aging3
Antimicrobial and infectious disease2

Registered clinical trials

2 of 11 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 11 · Recruiting: 3 · Terminated: 1
Phase 1: 8 · Phase 2: 5 · Phase 3: 2

TrialStatusPhaseStartedResults
Kisspeptin to Quantify GnRH Neuronal Function in Health and DiseaseNCT07224490 · 40 enrolledRecruitingPhase 12026-03—
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic AmenorrheaNCT07224438 · 20 enrolledRecruitingPhase 22025-12—
Recall by Genotype: Neuropeptide StimulationNCT05901467 · 16 enrolledTerminatedPhase 12023-10Posted
Dampening the Reproductive Axis With Continuous KisspeptinNCT05971849 · 8 enrolledCompletedPhase 12023-10—
Kisspeptin Administration Subcutaneously to Patients With IHHNCT05896293 · 36 enrolledRecruitingPhase 22023-02—
Kisspeptin Administration Subcutaneously to Patients With Reproductive DisordersNCT05633966 · 13 enrolledCompletedPhase 12022-12—
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic HypogonadismNCT04648969 · 18 enrolledCompletedPhase 22019-05Posted
Administration of Kisspeptin in Patients With HyperprolactinemiaNCT02956447 · 36 enrolledCompletedPhase 22017-11Posted
Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in MenNCT03315325 · 15 enrolledCompletedPhase 32014-08—
Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.NCT03286517 · 30 enrolledCompletedPhase 32014-06—
Neuropeptides in Human ReproductionNCT01952782 · 61 enrolledCompletedPhase 12014-04—
Kisspeptin in the Evaluation of Delayed PubertyNCT01438034 · 24 enrolledCompletedPhase 12013-06—
The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) TreatmentNCT01667406 · 175 enrolledCompletedPhase 22012-06Posted
Elucidating Kisspeptin Physiology by Blocking Kisspeptin SignalingNCT01438073 · 96 enrolledCompletedPhase 12011-09—
Kisspeptin Administration in the AdultNCT00914823 · 256 enrolledCompletedPhase 12009-06—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Circulatory metastin/kisspeptin-1 in polycystic ovary syndrome: a systematic review and meta-analysis with diagnostic test accuracy.

    Reproductive biomedicine online · May 2, 2019 · Meta-analysis · cited 30 times

    PMID 31515170 · DOI 10.1016/j.rbmo.2019.04.018 · Reviews and meta-analyses

  2. Kisspeptin and its Current Clinical Status-A Systematic Review.

    Current medicinal chemistry · January 1, 2025 · Systematic review · cited 4 times

    PMID 38265397 · DOI 10.2174/0109298673251224230919093656 · Reviews and meta-analyses

  3. Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans.

    The Journal of clinical endocrinology and metabolism · October 1, 2025 · Randomized controlled trial · cited 2 times · open access

    PMID 40036336 · DOI 10.1210/clinem/dgaf128 · Human clinical research

  4. Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans.

    EBioMedicine · April 11, 2025 · Randomized controlled trial · cited 6 times · open access

    PMID 40215751 · DOI 10.1016/j.ebiom.2025.105689 · Human clinical research

  5. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.

    JAMA network open · February 1, 2023 · Randomized controlled trial · cited 31 times · open access

    PMID 36735255 · DOI 10.1001/jamanetworkopen.2022.54313 · Human clinical research

  6. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.

    JAMA network open · October 3, 2022 · Randomized controlled trial · cited 29 times · open access

    PMID 36287566 · DOI 10.1001/jamanetworkopen.2022.36131 · Human clinical research

  7. A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.

    Human reproduction (Oxford, England) · September 1, 2017 · Randomized controlled trial · cited 71 times · open access

    PMID 28854728 · DOI 10.1093/humrep/dex253 · Human clinical research

  8. Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.

    The Journal of clinical endocrinology and metabolism · July 20, 2015 · Randomized controlled trial · cited 153 times · open access

    PMID 26192876 · DOI 10.1210/jc.2015-2332 · Human clinical research

  9. Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men.

    British journal of clinical pharmacology · February 1, 2013 · Randomized controlled trial · cited 46 times · open access

    PMID 22803642 · DOI 10.1111/j.1365-2125.2012.04385.x · Human clinical research

  10. Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea.

    Clinical pharmacology and therapeutics · October 27, 2010 · Randomized controlled trial · cited 132 times

    PMID 20980998 · DOI 10.1038/clpt.2010.204 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.

    Nature · May 1, 2001 · In vitro study · cited 1,448 times

    PMID 11385580 · DOI 10.1038/35079135 · In vitro studies

  2. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse.

    Endocrinology · June 24, 2004 · Animal study · cited 1,160 times

    PMID 15217982 · DOI 10.1210/en.2004-0431 · Animal studies

  3. Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide.

    Endocrinology · July 8, 2004 · Animal study · cited 711 times

    PMID 15242985 · DOI 10.1210/en.2004-0413 · Animal studies

  4. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males.

    The Journal of clinical endocrinology and metabolism · September 20, 2005 · Randomized controlled trial · cited 656 times

    PMID 16174713 · DOI 10.1210/jc.2005-1468 · Human clinical research

  5. Involvement of anteroventral periventricular metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing hormone release in female rats.

    The Journal of reproduction and development · January 10, 2007 · Animal study · cited 579 times · open access

    PMID 17213691 · DOI 10.1262/jrd.18146 · Animal studies

Latest publications

  1. Follicular kisspeptin-VEGF axis in polycystic ovary syndrome and ovarian hyperstimulation syndrome.

    Journal of assisted reproduction and genetics · August 28, 2026 · Observational human study · cited 0 times

    PMID 42663893 · DOI 10.1007/s10815-026-04014-w · Human clinical research

  2. Seminal Plasma Kisspeptin-1 and Kisspeptin-54 Levels Are Associated With Semen Parameters and Oxidative Stress in Male Infertility.

    Clinical endocrinology · August 7, 2026 · Observational human study · cited 0 times · open access

    PMID 42566672 · DOI 10.1111/cen.70199 · Human clinical research

  3. Kisspeptin-54 attenuates acute lung injury in septic mice through AMPK-mediated suppression of NLRP3 inflammasome.

    Neuropeptides · June 23, 2026 · Animal study · cited 0 times

    PMID 42418889 · DOI 10.1016/j.npep.2026.102639 · Animal studies

  4. Therapeutic potential of nasal kisspeptin-54 for reducing α-synuclein accumulation and restoring hippocampal synaptic plasticity in a 6-hydroxydopamine-induced rat model of Parkinson's disease.

    Turkish journal of medical sciences · June 19, 2026 · Animal study · cited 0 times · open access

    PMID 42676968 · DOI 10.55730/1300-0144.6376 · Animal studies

  5. Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography-High-Resolution Mass Spectrometry for Doping Control Purposes.

    Drug testing and analysis · April 29, 2026 · In vitro study · cited 0 times · open access

    PMID 42057309 · DOI 10.1002/dta.70081 · In vitro studies

  6. Kisspeptin-54 confers renal protection in diabetic nephropathy by ameliorating endothelial permeability through ZEB1 inhibition.

    Tissue & cell · March 27, 2026 · Animal study · cited 0 times

    PMID 41950743 · DOI 10.1016/j.tice.2026.103503 · Animal studies

  7. Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer.

    Molecular pharmaceutics · March 3, 2026 · In vitro study · cited 0 times · open access

    PMID 41774810 · DOI 10.1021/acs.molpharmaceut.5c01853 · In vitro studies

  8. Serum Kisspeptin levels in patients undergoing maintenance hemodialysis: a case-control study protocol.

    BMC nephrology · October 28, 2025 · Observational human study · cited 0 times · open access

    PMID 41152775 · DOI 10.1186/s12882-025-04512-6 · Human clinical research

  9. Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans.

    The Journal of clinical endocrinology and metabolism · October 1, 2025 · Randomized controlled trial · cited 2 times · open access

    PMID 40036336 · DOI 10.1210/clinem/dgaf128 · Human clinical research

  10. Kisspeptin-54 ameliorates chondrocyte senescence in osteoarthritis via SIRT3-mediated telomere protection and p53 acetylation inhibition.

    Neuropeptides · September 19, 2025 · Animal study · cited 2 times

    PMID 41022004 · DOI 10.1016/j.npep.2025.102562 · Animal studies

Browse all 189 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Kisspeptin-54; Kp-54; Metastin

((TITLE_ABS:"Kisspeptin-54" OR CHEM:"Kisspeptin-54" OR TITLE_ABS:"Kisspeptin54" OR CHEM:"Kisspeptin54") OR (TITLE_ABS:"Kp-54" OR CHEM:"Kp-54" OR TITLE_ABS:"Kp54" OR CHEM:"Kp54") OR (TITLE_ABS:"Metastin" OR CHEM:"Metastin")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 9). Kisspeptin-54 (Metastin) research statistics (Version weekly-2026-11-08) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/kisspeptin-54